
Elixir AI is a platform revolutionizing paediatric research by enabling doctors to design, conduct, and analyze clinical trials with reduced administrative burden and costs. The platform offers intuitive trial design tools with automated regulatory compliance, digital participant recruitment and consent, remote data collection, and AI-powered analytics for actionable insights. It supports collaboration among paediatricians, parents, and scientists, accelerating research impact and improving child health outcomes. Elixir AI operates on a cost-effective model, free for doctors, sharing grant funding among collaborators, and also offers paid services for pharmaceutical and biotech companies for post-market approval studies. The platform emphasizes data security and regulatory compliance, positioning itself as a specialized alternative to traditional Contract Research Organizations (CROs) focused on paediatric trials.

Elixir AI is a platform revolutionizing paediatric research by enabling doctors to design, conduct, and analyze clinical trials with reduced administrative burden and costs. The platform offers intuitive trial design tools with automated regulatory compliance, digital participant recruitment and consent, remote data collection, and AI-powered analytics for actionable insights. It supports collaboration among paediatricians, parents, and scientists, accelerating research impact and improving child health outcomes. Elixir AI operates on a cost-effective model, free for doctors, sharing grant funding among collaborators, and also offers paid services for pharmaceutical and biotech companies for post-market approval studies. The platform emphasizes data security and regulatory compliance, positioning itself as a specialized alternative to traditional Contract Research Organizations (CROs) focused on paediatric trials.
Core product: ML analysis of cough and breath audio to support remote diagnosis of childhood respiratory conditions
Headquarters: London, England, United Kingdom
Founders: Alex Palmer-Walsh; Ed Cartwright
Team size: 1–10 employees
Latest funding type: Grant
Pediatric respiratory diagnosis and remote health diagnostics
2017
DeepTech
6532
“Arise Innovation Hubs”